Date
Promethera's CSMO, Prof Dr Etienne Sokal, will present "HepaStem for the treatment of fibro-inflammatory liver diseases" at the 3rd Annual NASH Summit. The congress will be held in Boston, MA, US. For more information click here.
Promethera's CSMO, Prof Dr Etienne Sokal, will present "HepaStem for the treatment of fibro-inflammatory liver diseases" at the 3rd Annual NASH Summit. The congress will be held in Boston, MA, US. For more information click here.